Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25348323 | 0.81 | OPRM1 (0.45) | SMN1; SMN2LMNAOPRM1OPRD1OPRK1 | |
| SCHEMBL28048346 | 0.80 | OPRM1 (0.46) | SMN1; SMN2LMNAOPRM1OPRD1OPRK1 | |
| SCHEMBL19753650 | 0.79 | ADORA3 (0.40) | CYP19A1ALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL19753659 | 0.77 | ADORA3 (0.39) | ALDH1A1SMN1; SMN2LMNAMAPTRAB9A | |
| SCHEMBL25139570 | 0.77 | SMN1; SMN2 (0.51) | ALDH1A1SMN1; SMN2LMNAMAPTRAB9A | |
| SCHEMBL26104235 | 0.76 | OPRM1 (0.46) | CYP19A1ALDH1A1LMNAOPRM1OPRD1 | |
| SCHEMBL290857 | 0.75 | HDAC4 (0.50) | CYP19A1ALDH1A1OPRM1OPRD1OPRK1 | |
| SCHEMBL22790441 | 0.74 | OPRM1 (0.60) | ALDH1A1LMNAOPRM1OPRD1OPRK1 | |
| SCHEMBL3554785 | 0.73 | DRD3 (0.54) | SMN1; SMN2OPRM1OPRD1OPRK1DRD3 | |
| SCHEMBL8780436 | 0.71 | POLB (0.43) | CYP19A1ALDH1A1SMN1; SMN2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10449173-B2 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | ALLERGAN SALES, LLC (US) | 2019-10-22 | — | — | US | disclosed |
| EP-3287122-B1 | DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS FOR TREATING OVERACTIVE BLADDERS. | ALLERGAN SALES LLC (US) | 2019-04-17 | — | — | EP | disclosed |
| EP-3287122-A1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | Allergan Sales, LLC (US) | 2018-02-28 | — | — | EP | disclosed |
| EP-2427172-B1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | ALLERGAN SALES LLC (US) | 2017-11-01 | — | — | EP | disclosed |
| US-20160128963-A1 | METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | WATSON LABORATORIES, INC. | 2016-05-12 | — | — | US | disclosed |
| US-9259388-B2 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | WATSON PHARMACEUTICALS, INC. (US) | 2016-02-16 | — | — | US | disclosed |
| US-8920392-B2 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | WATSON LABORATORIES, INC. (US) | 2014-12-30 | — | — | US | disclosed |
| US-20140046275-A1 | Method for Treating Overactive Bladders and a Device for Storage and Administration of Topical Oxybutynin Compositions | WATSON LABORATORIES, INC. (US) | 2014-02-13 | — | — | US | disclosed |
| EP-2427172-A2 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | Watson Laboratories, Inc. (US) | 2012-03-14 | — | — | EP | disclosed |
| WO-2010129498-A2 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | WATSON LABORATORIES, INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| US-20100286630-A1 | Method For Treating Overactive Bladders And A Device For Storage And Administration Of Topical Oxybutynin Compositions | WATSON LABORATORIES, INC. (US) | 2010-11-11 | — | — | US | disclosed |